Health and care systems are undergoing a significant digital transformation across Europe and the world. Health services and procedures are becoming increasingly digitised, and novel digital technologies, such as medical devices, procedures, and diagnostic tools, are emerging every day. The adoption of digital technologies can make health systems more sustainable, responsive, resilient, and patient-centred, leading us towards a healthier society. However, to maximise the potential of digital technologies, health managers need effective decision-making tools to navigate the complexities of digital transformation at a systemic level.
One such tool that can assist health managers in making evidence-based decisions is Health Technology Assessment (HTA). HTA is a scientific, multidisciplinary, and evidence-based process that evaluates the added value of new technologies at various stages of their life cycle. By facilitating managerial processes and enhancing the quality, equity, and efficiency of care delivery, HTA serves as a valuable tool that can support decision-making. HTA is also a key area of focus on the EU health policy agenda, with the Regulation on Health Technology Assessment (EU) scheduled to come into effect in 2025 to promote collaboration and coordination among EU Member States.
This plenary session will discuss the potential of HTA in managing digital transformation in health and care systems. Panelists will showcase examples of solution-oriented, evidence-based managerial tools that have proven successful and highlight HTA’s critical role as a decision-making tool for health systems, organisations, and hospitals. Attendees will learn how HTA can help make informed decisions about adopting new digital technologies, ultimately leading to a more sustainable and efficient healthcare system.
The session will feature as keynote speaker Dr Rabia Kahveci, Vice President at HTA International; Mr Marco Greco, President of the European Patient Forum; Dr Iga Lipska, Chairwoman of the Board at the Health Policy Institute; Dr Marco Marchetti, Director at AGENAS; Dr Dimitra Panteli, Programme Manager at the European Observatory on Health Systems and Policies; and Dr Laura Sampietro-Colom, Head of Innovation Assessment Unit (Health Technology Assessment) at Hospital Clinic Barcelona. Prof Americo Cicchetti, Director at ALTEMS – Graduate School of Health Economics and Management, Università Cattolica del Sacro Cuore will facilitate the discussion.
Check out the #EHMA2023 programme here and discover the over 50 sessions we have this year. Don’t miss your chance to attend EHMA 2023 – book your spot before Friday, 26 May here.